Kevin Bitterman Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Kevin Bitterman is of Gemini Therapeutics, Inc. . Currently has a direct ownership of 0 shares of GMTX, which is worth approximately $0. The most recent transaction as insider was on Dec 15, 2025, when has been sold 7,000 shares (Common Stock) at a price of $91.87 per share, resulting in proceeds of $643,090. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Kevin Bitterman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2025
SELL
Open market or private sale
$643,090 $91.87 p/Share
7,000 Reduced 100.0%
0 Common Stock
Dec 15 2025
BUY
Exercise of conversion of derivative security
$94,500 $13.5 p/Share
7,000 Added 50.0%
7,000 Common Stock

Also insider at

AKRO
Akero Therapeutics, Inc. Healthcare
Director
KB

Kevin Bitterman

South San Francisco, CA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX